Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that individuals with a rare genetic disorder linked to the AEBP1 gene may experience a unique type of hair loss and should be monitored for heart issues.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Alopecia areata may be linked to heart issues.

PCOS often leads to sleep problems, especially obstructive sleep apnea, affecting overall health.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document covers various male health issues, their causes, treatments, and related conditions.

Men can report their own balding patterns well enough for large health studies.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Proper nutrition can help manage PCOS symptoms and improve overall health.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.